Our Co-Chair Glen Tupuhi has sent a submission on behalf of Te Tiratū Iwi Māori Partnership Board opposing Pharmac’s proposal to remove ethnic equity criteria for type 2 diabetes medicines (SGLT2 inhibitors and GLP-1 receptor agonists). The consultation closes 28 May 2026.